JP2005536465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005536465A5 JP2005536465A5 JP2004503480A JP2004503480A JP2005536465A5 JP 2005536465 A5 JP2005536465 A5 JP 2005536465A5 JP 2004503480 A JP2004503480 A JP 2004503480A JP 2004503480 A JP2004503480 A JP 2004503480A JP 2005536465 A5 JP2005536465 A5 JP 2005536465A5
- Authority
- JP
- Japan
- Prior art keywords
- defined above
- substituted
- aryl
- heteroaryl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14439602A | 2002-05-13 | 2002-05-13 | |
| PCT/US2003/014914 WO2003095466A1 (en) | 2002-05-13 | 2003-05-13 | 6,11 bicyclic erythromycin derivatives |
| US10/436,622 US7129221B2 (en) | 2002-05-13 | 2003-05-13 | 6,11-bicyclic erythromycin derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005536465A JP2005536465A (ja) | 2005-12-02 |
| JP2005536465A5 true JP2005536465A5 (enExample) | 2006-04-20 |
Family
ID=34067652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004503480A Ceased JP2005536465A (ja) | 2002-05-13 | 2003-05-13 | ６，１１二環式エリスロマイシン誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7129221B2 (enExample) |
| EP (1) | EP1509538A1 (enExample) |
| JP (1) | JP2005536465A (enExample) |
| KR (1) | KR100661973B1 (enExample) |
| CN (1) | CN1659178A (enExample) |
| NZ (1) | NZ536402A (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6841664B2 (en) * | 2002-07-25 | 2005-01-11 | Enanra Pharmaceuticals, Inc. | 6,11-4-carbon bridged ketolides |
| US7273853B2 (en) * | 2002-05-13 | 2007-09-25 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
| US7910558B2 (en) * | 2002-05-13 | 2011-03-22 | Enanta Pharmaceuticals, Inc. | Bridged macrocyclic compounds and processes for the preparation thereof |
| US7135573B2 (en) * | 2002-05-13 | 2006-11-14 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine |
| TW200420573A (en) * | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
| AU2004217919A1 (en) * | 2003-03-05 | 2004-09-16 | Rib-X Pharmaceuticals, Inc. | Bifunctional heterocyclic compounds and methods of making and using the same |
| WO2005042554A1 (en) * | 2003-10-30 | 2005-05-12 | Rib-X Pharmaceuticals, Inc. | Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| US20070270357A1 (en) * | 2003-11-18 | 2007-11-22 | Farmer Jay J | Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same |
| US7414030B2 (en) * | 2004-01-07 | 2008-08-19 | Enanta Pharmaceuticals, Inc. | 6-11 Bicyclic erythromycin derivatives |
| WO2005070113A2 (en) * | 2004-01-09 | 2005-08-04 | Enanta Pharmaceuticals, Inc. | 9n-substituted 6-11 bicyclic erythromycin derivatives |
| US7384921B2 (en) * | 2004-02-20 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | Polymorphic forms of 6-11 bicyclic ketolide derivatives |
| EP1723159B1 (en) * | 2004-02-27 | 2019-06-12 | Melinta Therapeutics, Inc. | Macrocyclic compounds and methods of making and using the same |
| US20060058247A1 (en) * | 2004-09-16 | 2006-03-16 | Yujiro Hata | Methods and compositions for treating cystic fibrosis |
| CA2598139A1 (en) * | 2005-02-21 | 2006-08-24 | Alpharma Aps | Method for the production of macrolides |
| US7384922B2 (en) * | 2005-05-04 | 2008-06-10 | Enanta Pharmaceuticals, Inc. | 6-11 bridged oxime erythromycin derivatives |
| US20060264386A1 (en) * | 2005-05-17 | 2006-11-23 | Rongqi Sun | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof |
| JP2009539866A (ja) * | 2006-06-05 | 2009-11-19 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換エリスロマイシンアナログの調製および有用性 |
| US8273720B2 (en) * | 2007-09-17 | 2012-09-25 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl macrolide derivatives |
| US8354383B2 (en) * | 2007-09-17 | 2013-01-15 | Enanta Pharmaceuticals, Inc. | 6,11-bridged biaryl macrolides |
| EP2203435B1 (en) * | 2007-09-17 | 2018-07-18 | Enanta Pharmaceuticals, Inc. | 6, 11-bridged biaryl macrolides |
| US20090131343A1 (en) * | 2007-11-15 | 2009-05-21 | Ly Tam Phan | Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases |
| WO2009137787A1 (en) | 2008-05-09 | 2009-11-12 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives |
| WO2009137739A1 (en) * | 2008-05-09 | 2009-11-12 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of o-[5-[4-amino-thiazol-2-yl]-pyridin-2-ylmethyl]-hydroxylamine |
| TW200946109A (en) * | 2008-05-09 | 2009-11-16 | Enanta Pharm Inc | Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides |
| WO2010096051A1 (en) * | 2009-02-18 | 2010-08-26 | Enanta Pharmaceuticals, Inc. | 6,11-bicyclolides: bridged biaryl amide macrolide derivatives |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| CN116947687B (zh) * | 2022-04-14 | 2025-07-18 | 帕潘纳(北京)科技有限公司 | 吡唑类除草剂中间体及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR960000434B1 (ko) | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
| IL99995A (en) | 1990-11-21 | 1997-11-20 | Roussel Uclaf | Erythromycin derivatives, their preparation and pharmaceutical compositions containing them |
| EP0559896B1 (en) | 1990-11-28 | 1997-08-27 | Taisho Pharmaceutical Co. Ltd | 6-o-methylerythromycin a derivative |
| ATE135707T1 (de) | 1992-04-22 | 1996-04-15 | Taisho Pharmaceutical Co Ltd | 5-0-desosaminylerythronolid a derivate |
| US5527780A (en) | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
| FR2738571B1 (fr) | 1995-09-11 | 1997-10-17 | Roussel Uclaf | Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs |
| UA51730C2 (uk) | 1996-09-04 | 2002-12-16 | Ебботт Лабораторіз | 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців |
| CO4990972A1 (es) | 1997-10-29 | 2000-12-26 | Abbott Lab | Derivados de eritromicina en puente 6,11 |
| US6124269A (en) | 1997-10-29 | 2000-09-26 | Abbott Laboratories | 2-Halo-6-O-substituted ketolide derivatives |
| US6046171A (en) | 1997-10-29 | 2000-04-04 | Abbott Laboratories | 6,11-bridged erythromycin derivatives |
| CA2370743A1 (en) | 1999-04-16 | 2000-10-26 | Dennis Hlasta | Ketolide antibacterials |
| US6878691B2 (en) * | 2002-05-13 | 2005-04-12 | Enanta Pharmaceuticals, Inc. | 6-11 bicyclic ketolide derivatives |
-
2003
- 2003-05-13 US US10/436,622 patent/US7129221B2/en not_active Expired - Lifetime
- 2003-05-13 JP JP2004503480A patent/JP2005536465A/ja not_active Ceased
- 2003-05-13 EP EP03726818A patent/EP1509538A1/en not_active Withdrawn
- 2003-05-13 CN CN038136236A patent/CN1659178A/zh active Pending
- 2003-05-13 KR KR1020047018367A patent/KR100661973B1/ko not_active Expired - Fee Related
- 2003-05-13 NZ NZ536402A patent/NZ536402A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005536465A5 (enExample) | ||
| CY1110232T1 (el) | Παραγωγα 2-αρυλ-6-φαινυλ-ιμιδαζο[1,2-α]πυριδιν, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη αγωγη | |
| RU2014140739A (ru) | Соединения на основе имидазо[1, 2-b]пиридазина, композиции таких соединений и способы их применения | |
| CY1108752T1 (el) | Παραγωγα πουρινης δρωντα ως αγωνιστες του α2α-υποδοχεα | |
| RU2013140798A (ru) | Трициклические ингибиторы гиразы | |
| JP5739882B2 (ja) | Ｎ４−（２，２−ジメチル−４−［（二水素ホスホノオキシ）メチル］−３−オキソ−５−ピリド［１，４］オキサジン−６−イル）−５−フルオロ−ｎ２−（３，４，５−トリメトキシフェニル）−２，４−ピリミジンジアミン二ナトリウム塩の合成 | |
| RU2018129308A (ru) | Новые производные аммония, способ их получения и фармацевтические композиции, содержащие их | |
| JP2009504669A5 (enExample) | ||
| CY1114932T1 (el) | Αντιπαρασιτικοι παραγοντες | |
| JP2014510774A5 (enExample) | ||
| RU2007136964A (ru) | Способ получения макроциклических соединений | |
| MX2010008101A (es) | Derivados de indol 2-carboxamidas y de azaindol 2-carboxamidas sustituidos con un silanilo, su preparacion y su aplicacion en terapeutica. | |
| RU2009105669A (ru) | Способ получения 3-замещенных 2-амино-5-галогенбензамидов | |
| CY1116540T1 (el) | Μεθοδος παραγωγης 2'-δεοξυ-5-αζακυτιδινης (δεσιταβινη) | |
| CY1114418T1 (el) | Αλατα προσθηκης αμινων που περιεχουν υδροξυλικες ή/και καρβοξυλικες ομαδες με παραγωγα αμινονικοτινικου οξεως ως αναστολεις της dhodh | |
| RU2011133128A (ru) | Противоопухолевые соединения дигидропиран-2-она | |
| CA2483678A1 (en) | 6-11 bicyclic ketolide derivatives | |
| ATE296300T1 (de) | Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel | |
| NZ332923A (en) | Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents | |
| RU2008150498A (ru) | Новый кристалл фосфата 5-аминолевулиновой кислоты и способ его получения | |
| RU2008118422A (ru) | Производные 5-хинолина, обладающие антибактериальной активностью | |
| TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
| TW200716527A (en) | Substituted aminoalkyl-and amidoalkyl-benzopyran derivatives | |
| JP2008517965A5 (enExample) | ||
| WO2008123349A1 (ja) | Ｎ－フェニル－ｎ’－フェニルスルホニルピペラジン誘導体の製造方法 |